Combination of low doses of amlodipine with low doses of either famotidine or omeprazole produced significant antiulcer effects. It is suggested that the patients who received amlodipine therapy for some other clinical conditions are less prone to develop peptic ulcers; and even if ulcers develop, they would require lower doses of antiulcer agents like famotidine and omeprazole.
Introduction
Peptic ulcer disease is a major health problem with multifactorial etiology. The development of gastric ulcer occurs with acid and the breakdown of mucosal defence. Local mechanisms implicated in mucosal defence are; mucus-like alkaline secretions, mucosal hydrophilicity, rapid epithelial cell renewal, rich mucosal blood flow, mucosal sulphydryls and increased resistance of gland cells in deep mucosa to acid and peptic activity. [1] Calcium ions are involved in the regulation of acid secretion in the stomach [2, 3] and has been considered as a serious contender responsible for the development of various types of ulcers. [4] Calcium influx plays an important role in stimulationsecretion coupling in mammalian oxyntic cells, an effect that can be inhibited by calcium channel blockers. [5] Moreover, calcium channel blockers exert an inhibitory effect on histamine-, gastrin-, carbachol-and cyclic-AMP-induced stimulation of gastric acid secretion. [6] So, there is a possibility that calcium channel blockers, which act by reducing the transmembrane calcium influx, may influence the secretion of hydrochloric acid in the stomach and thus may have a protective effect against gastric ulcers.
The gastroprotective effects of calcium channel blockers, viz., verapamil, nifedipine and diltiazem, have been reported. [7] [8] [9] Nifedipine, verapamil and diltiazem have been reported to potentiate the antiulcer and antisecretory effects of famotidine at low doses. [10] Amlodipine, a long-acting calcium channel blocker is at present widely used in clinical practice for the management of various cardiovascular disorders. It is likely that because of its long action, the gastric protective effects of amlodipine may differ from that of other calcium channel blockers. But, at present, the data regarding the interaction of amlodipine with various antiulcer agents are not available. Therefore, the present study was undertaken to evaluate the effects of the slow-and long-acting calcium channel blocker, amlodipine, on gastric secretion and other parameters as well as its interaction with a H 2 -blocker, famotidine, and a proton-pump inhibitor, omeprazole, in pylorus-ligated gastric ulcer model in rats.
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Total mucosal area Ulcer index = --where, X = ---------X Total ulcerated area was cut open along the greater curvature and the inner surface was examined for ulceration with the help of a simple dissecting microscope. Usually, circular lesions were observed but, sometimes, linear lesions were also seen. The ulcer index was calculated by using the formula.
[12]
Drugs used
Fresh solutions of amlodipine besylate (Intas Pharmaceuticals, Ahmedabad), famotidine (Sun Pharmaceutical Industries, Vadodara) and omeprazole (Cipla, Mumbai) were prepared daily in DMSO.
Statistical analysis
All data are expressed as mean+SEM. Effects of famotidine with famotidine (1 mg/kg) and amlodipine (0.25 mg/kg) with Famotidine in a dose of 1 mg/kg did not produce any omeprazole (1mg/kg). All drugs were administered significant change in any of the parameters studied. [ Table 1 ] intraperitoneally ( i.p.) 1 h prior to pyloric ligation (PL), except However 4 mg/kg famotidine produced significant decrease in amlodipine which was given 4 h prior to PL and two groups the volume of gastric secretion, free acid, total acid and ulcer treated with DMSO -one receiving DMSO 4 h prior to PL and index alongwith significant (P<0.01) increase in the pH as the other 1 h prior to PL. Control group received normal saline.
compared to the control. [ Table 1 ] The volume of all the above injections varied between 0.2 to Effects of omeprazole Omeprazole in a dose of 1 mg/kg produced a significant Pyloric ligation was performed as described by Shay (P<0.05) decrease in the volume of gastric secretion as [11] Rats were fasted for 36 h prior to the surgical procedure compared to the control value without significantly modifying and kept in raised mesh-bottomed cages to avoid coprophagy. the pH, free acid, total acid and ulcer index values. [ Table 1 ] Under urethane anesthesia (80 mg/100 g, i.p.) the abdomen Whereas, omeprazole in doses of 2 mg/kg and 4 mg/kg was opened by a small midline incision below the xiphoid produced significant (P<0.01) dose-dependent increase in pH process. The pyloric portion of the stomach was identified, value and significant dose-dependent decrease in other slightly lifted out and ligated, avoiding traction to the pylorus parameters, as compared to the control values. [ Table 1 ] or damage to the blood supply. The stomach was then replaced carefully and the abdominal wall closed by interrupted sutures.
Effects of amlodipine
Animals were deprived of both food and water during the Amlodipine in a dose of 0.25 mg/kg did not modify any of ad libitum.
0.4 ml.
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postoperative period and were sacrificed at the end of 19-20 h after the operation. The stomach was dissected out as a whole by passing a ligature at the esophageal end. The stomach was separated from the surrounding tissues and organs and thus brought out as a whole alongwith its contents. The contents were subjected to centrifugation (3000 rpm for 10 min) and then analyzed for volume, pH, and free and total acidity.
The pH was estimated using Indikrom pH strips (Glaxo India Limited, India) with pH ranges of 2.0-4.5 and 5.0-8.5 with a difference in range of 0.5. Free acidity and total acidity were estimated by titrating 1 ml of the centrifuged sample with 0.01 N NaOH, using Topfer's indicator and phenolpthalein indicator, respectively. Acidity was expressed in clinical units, i.e the amount of 0.01 N NaOH base required to titrate 100 ml of gastric secretion. For estimation of ulcer index, the stomach the parameters significantly. However, in doses of 0.5 mg/kg and 1 mg/kg, it produced a dose-dependent decrease in the volume of gastric secretion, free acid, total acid and ulcer index and a significant increase in the pH values, as compared to the control values. [ Table 2 ]
Effects of combined treatments
Combined treatment consisting of famotidine (1 mg/kg) with amlodipine (0.25 mg/kg) produced a significant (P<0.01) decrease in the volume of gastric secretion, free acid, total acid and ulcer index with a significant increase in the pH values, as compared to the control values as well as to the groups that received either famotidine or amlodipine alone. [ Table 3 ]
Combination of omeprazole (1 mg/kg) and amlodipine (0.25 mg/kg) also produced a significant (P<0.01) decrease in the values of all the parameters, with a significant increase in the pH values, as compared to the control values as well as to the Interaction of amlodipine with famotidine and omeprazole groups that received either omeprazole or amlodipine alone.
[ Table 3 ]
Discussion
The etiology of peptic ulcer is unknown in most of the cases, yet it is generally accepted that it results from an imbalance between aggressive factors and the maintenance of mucosal integrity through the endogenous defense mechanisms.
[13] To regain the balance, different therapeutic agents are used to inhibit the gastric acid secretion or to boost the mucosal defense mechanisms by increasing mucus production, stabilizing the surface epithelial cells or interfering with the using three calcium channel blockers, viz., verapamil, diltiazem and nifedipine, reported a decrease in gastric acid secretion and a rise in the TC/PR ratio { TC = total carbohydrate content of gastric juice, PR = total protein content of gastric juice }, indicating improved mucus activity, which in turn strengthens mucosal barrier; as possible mechanisms of antiulcer activity of all the three calcium channel blockers. Therefore, it seems likely that amlodipine may be acting by the similar mechanisms as reported above.
A role for reactive oxygen metabolites, free radicals and nitric oxide has been suggested in the pathogenesis of gastric ulcer.
[21 -24] Recently, Ding and Vaziri [25] reported that prototypes prostaglandin synthesis. [14] of dihydropyridines like nifedipine up-regulate the nitric oxide The causes of gastric ulcer after pyloric ligation are believed (NO) system in endothelial cells suggesting, in part its different to be due to stress-induced increase in gastric hydrochloric biological properties. Amlodipine has also been reported to acid secretion and/or stasis of acid. According to Shay et al., increase NO release from the coronary microvasculature of the volume of secretion is also an important factor in the failing human myocardium. [26] Thus, it is tempting to suggest formation of ulcer due to exposure of the unprotected lumen that the amlodipine-induced protective effects in pylorusof the stomach to the accumulating acid.
ligated gastric ulcers could be in part also mediated through Famotidine, a competitive antagonist of H 2 -receptor, is either a decrease in free-radical generation or an increase in capable of reducing over 90% of basal and nocturnal secretion nitric oxide production. Further study is necessary to identify of gastric acid and that stimulated by food, histamine, gastrin, the role of amlodipine on the above factors. cholinomimetic drugs and vagal stimulation.
[15] Famotidine In the present study, low doses of either famotidine reduces acidity and volume of gastric secretion by blocking
(1 mg/kg), omeprazole (1 mg/kg) or amlodipine (0.25 mg/kg) the effect of histamine. It can also reduce the gastrin and the did not produce any antiulcer effect. Higher doses of amlodipine vagus nerve-mediated secretion to some extent.
[10] Famotidine (0.5 mg and 1 mg/kg) produced a significant protective effect exerts its antisecretory effect by inhibiting the histamineagainst experimental gastric ulceration in rats. However, a induced cyclic-AMP-dependent pathway. [16] combination of low dose (0.25 mg/kg) of amlodipine with low The proton pump inhibitor omeprazole produces small and dose (1 mg/kg) of famotidine produced a significant antiulcer inconsistent changes in the volume of gastric secretion and in effect. Similarly, a low dose of amlodipine (0.25 mg/kg) the secretion of pepsin, but it does not affect gastric motility.
combined with a low dose of omeprazole (1 mg/kg) also It irreversibly inhibits the gastric acid (proton) pump which is produced significant antiulcer activity. It is likely that the final common pathway for acid secretion in response to all amlodipine like other dihydropyridine calcium channel varieties of stimuli. It produces virtual anacidity in vivo.
blockers [8, 10, 20] may have antiulcer activity through multiple In the present study, therapeutically equivalent doses of (2 or more) separate mechanisms, which are different from amlodipine (0.5 mg and 1 mg/kg) produced significant decrease the mechanisms of famotidine and omeprazole. in the volume, free acidity and total acidity of the gastric Hence, simultaneous administration of low doses of secretion alongwith a significant protective effect against amlodipine with either famotidine or omeprazole may produce gastric ulceration induced by pylorus ligation. A lower dose of significant antiulcer effects, as reflected by the reduction of 0.25 mg/kg did not produce any significant alteration in the volume of gastric secretion, acidity and ulcer index. parameters studied.
From the present investigation, it may be concluded that Gastric acid secretion is under vagal control and amlodipine produced a significant protective effect against overactivity of vagus also contributes to ulcer formation. [9] Vagal gastric ulceration and also produced significant antiulcer stimulation increases acetylcholine that acts directly on the muscarinic receptors on parietal cells and secretes hydrochloric acid through a calcium-dependent pathway. [16] Mandal et al., [10] have shown that the protective effect of verapamil and nifedipine against gastric ulcer may partly be due to inhibition of this calcium-dependent pathway. The gastric antisecretory effect of amlodipine may be due to a similar mechanism. Amlodipine may also act by antagonizing the injurious effects of histamine and other biogenic amines on the capillaries of gastric mucosa, as suggested for nifedipine and verapamil. [8, 10] Verapamil has been reported to inhibit mast-cell degranulation, [9] acid secretion [17, 18] and gastric motility. Koo et al., [19] reported antiulcer activity of verapamil in stressinduced ulcer formation based upon its action on the preservation of mucus. Jain et al., [8, 9] and Jain and Santani, [20] effects when used in combination with famotidine and omeprazole. It is to be studied whether doses of famotidine and omeprazole could be reduced for the management of peptic ulcer in patients who are on amlodipine therapy. ) .
